Loperamide Hcl
Pricing Report NDC 62011-0158-1

Latest NADAC: $0.15021 per EA · Effective Aug 19, 2020 · Est. package price $3.61 (24 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Loperamide Hcl (NDC 62011-0158-1) is $0.15021 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2020.

As a provided by Mckesson (health Mart), this medication is distributed in a 2 BLISTER PACK in 1 BOX / 12 CAPSULE, LIQUID FILLED in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.15021
Per EA

Effective Date
Aug 19, 2020
Billable Units
24 EA
Estimated Package Price
$3.61
Data Status
As of Sep 02, 2020
C/I - Chain or Independent Pharmacy
Package NDC
Description
2 BLISTER PACK in 1 BOX / 12 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.10619 to $0.16250 per EA. Over this 6 years and 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.1062 - $0.1625
Market Volatility
53.03% Variance
Latest Trend
11.48%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2020 $0.15021 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 22, 2020 $0.13474 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 17, 2020 $0.14259 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2020 $0.13482 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2020 $0.14427 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2020 $0.13994 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2020 $0.16250 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2020 $0.14581 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2019 $0.14511 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 20, 2019 $0.15615 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 20, 2019 $0.15615 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2019 $0.14386 EAC/I - Chain or Independent PharmacyCode 1G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026